Site updated at Wednesday, 22 June 2016

Living with Dementia

Functional Imaging

  • - Normal Aging & Dementia
  • Jun 25, 2011
  • Comments
  • Viewed: 2665
Tags: | brewer | dat | dementia of the alzheimer type | emission computed tomography |

Functional imaging methods used in research on aging, mild cognitive impairment, and dementia of the Alzheimer type include single-photon emission computed tomography (SPECT),  positron emission tomography (PET),  and functional magnetic resonance imaging (fMRI). Positron emission tomography and single-photon emission computed tomography use radioisotope tracers to detect brain metabolism or blood flow. Functional magnetic resonance imaging is a method that indicates regions of activation by detecting changes in blood oxygenation in capillaries. Normally, brain metabolism, blood flow, and neuronal activity are tightly coupled. The extent to which this relationship is altered in normal aging and DAT requires further investigation (D’Esposito et al. 1997; Ross et al. 1997; Johnson et al. 2001).

Functional imaging research involves several types of study design. Resting state studies examine metabolism or activity in various regions of the brain without engaging the participants in a particular activity or cognitive task.

Other studies correlate resting state activation with neuropsychological status on tests completed outside of the scanner. Finally, activation studies examine patterns of brain activity associated with cognitive activities in which the participant engages during scanning.

Resting State Single-photon Emission Computed Tomography and Postitron Emission Tomography Studies
Numerous resting state positron emission tomography studies of regional cerebral metabolic rates for glucose and oxygen indicate hypometabolism in all association cortices in dementia of the Alzheimer type, with temporoparietal regions generally most affected early in the disease (Herholz 1995; Pietrini et al. 2000; Coleman 2001). Bilateral hippocampal hypometabolism has also been reported in some (Perani et al. 1993) but not all (Ishii et al. 1998) studies. By contrast, primary sensory and motor areas and subcortical gray matter show relative metabolic preservation (Herholz 1995; Pietrini et al. 2000). Even in persons with early stages of DAT or with MCI, a similar pattern of hypometabolic regions has been demonstrated (Haxby et al. 1990; see Almkvist and Winblad 1999 for review). Using PET, DeSanti and colleagues (2001) showed metabolic reductions in both MCI and DAT relative to healthy age-matched controls. Metabolic reductions in the hippocampus and anterior parahippocampal gyrus discriminated persons with MCI from controls, whereas more widespread reductions in temporal regions of interest discriminated persons with DAT from those with MCI.

The general pattern of affected brain regions on positron emission tomography remains relatively stable over time.  The degree of hypometabolism is modestly correlated with disease severity (Parks, Haxby, and Grady 1993). Herholz and colleagues (1999) showed a relation between the degree of glucose hypometabolism at baseline and subsequent progression in DAT. In persons with mild cognitive deficits at study entry, the presence of severely impaired metabolism predicted a 4.7 times greater rate of progression relative to individuals whose metabolism was intact or only mildly impaired.

Significant relations have been demonstrated between the metabolic reductions in association cortex and neuropsychological impairment (Parks, Haxby, and Grady 1993). Using SPECT, Grossman et al. (1997) showed a relation between semantic memory and reduced perfusion in the left inferior parietal and superior temporal regions. PET studies have demonstrated patterns of cerebral glucose metabolism consistent with expected brain-behavior relations in DAT; for example, individuals with predominantly left hemispheric hypometabolism of association cortices showed greater verbal than visuospatial impairment (Grady et al. 1990). A recent advance is the use of special PET radioligand binding techniques to detect the level of cholinesterase activity in dementia of the Alzheimer type (Kuhl et al. 1999).

Functional Activation Studies

Functional activation studies examine patterns of brain activation that occur during task performance.  There are very few functional activation studies of memory in DAT or MCI, and they are mainly limited to the milder end of the disease spectrum. One hypothesis that has been addressed in some PET activation studies posits a shift in activation from expected foci to a more widespread cortical distribution during cognitive task performance in persons with DAT compared to healthy controls (e.g., Becker et al. 1996; Woodard et al. 1998).  This may reflect compensatory recruitment of remaining neural resources; however, studies to date have not ruled out loss of inhibitory neural processing leading to abnormally widespread activation (Saykin et al. 1999).

Several studies have shown abnormalities of mesial temporal activation on functional magnetic resonance imaging in persons with dementia of the Alzheimer type performing episodic memory encoding tasks (e.g., Rombouts et al. 2000). Small et al. (1999) reported diminished mesial temporal lobe activation in persons with DAT relative to controls. They also examined a group of older adults with isolated memory impairment; these individuals showed activation patterns that were either similar to those of persons with DAT, or that involved isolated hypoactivation of the subiculum.  Kato,  Knopman,  and Liu (2001) compared fMRI activation patterns for patients with mild DAT and young and old controls; all participants activated visual cortex, but DAT patients failed to activate entorhinal, other temporal, and frontal regions.

Page 1

1 2 Next »

Post a comment [ + Comment here + ]

There are no comments for this entry yet. [ + Comment here + ]

Your details

* Required field

Please enter the word you see in the image below:

Comments are moderated by our editors, so there may be a delay between submission and publication of your comment. Offensive or abusive comments will not be published.

Living with Dementia

amyloid-beta plaque1 - early-onset dementia2 - presbyophrenia1 - vascular damage1 - syndrome of dementia1 - symptoms of parkinson's disease1 - vci1 - development of parkinson's1 - als1 - parkinson's treatment1 - early alzheimer's disease1 - cerebral haemorrhage1 - amylin1 - icd-101 - alzheimer's disease prevention1 - sodium benzoate1 - visual hallucinations1 - dementia patients8 - restlessness1 - alzheimer's dementia2 - grandiosity1 - wernicke's encephalopathy4 - single-photon emission computed tomography1 - postitron emission tomography1 - repair damaged nerve tissue1 - senile atrophy and aphasia1 - atrial fibrillation1 - parkinson's sufferer1 - synthetic tau fibrils1 - hydrocephalus1 -